Case Study: Medisafe’s Next Gen Digital Drug Companion

4 Jan 2020

Digital Therapeutics is revolutionizing the future of healthcare. But no one could have predicted the acceleration of this evolution in response to the Coronavirus outbreak. The time is now to support patients through digital companions.

Download the study to learn how Medisafe’s digital drug companions in the emerging world of digital therapeutics are already delivering for pharma right now.

You may also like

Webinars

Inside CURE Epilepsy: Funding Science, Saving Lives

A cure mindset changes everything. That’s the animating force behind our conversation with Beth Dean, CEO of CURE Epilepsy, as 

..Read More
Webinars

Innovating Rare Disease Treatment: Integrating Digital Tools from Day One

In this webinar, UCB Pharma and the Les Turner ALS Foundation joined Medisafe discuss the integration of digital tools in 

..Read More
Research

Medisafe Demonstrates Significant Impact on Medication Adherence in Medically Underserved Populations

BOSTON – Feb. 4, 2025 – A new study published in JMIR Human Factors has revealed promising clinical results showcasing 

..Read More

Want to Learn More?

We bring decades of experience to your challenges—and technology and solutions uniquely designed to meet your needs.